2022-09-12
ESHG Pharmacogenetics Course

International Scientific Committee

  • Vita Dolžan, chair (Faculty of Medicine, University of Ljubljana, Slovenia)
  • William Newman (Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, United Kingdom)
  • Sir Munir Pirmohamed (MRC Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine and Institute of Translational Medicine, University of Liverpool, United Kingdom)
  • Cristina Rodriguez-Antona (Spanish National Cancer Research Centre, Madrid, Spain)
  • Ron van Schaik (Erasmus Medical Center, Erasmus University Medical Centre, Rotterdam, The Netherlands)

Local organizing Committee

  • Vita Dolžan, chair
  • Katja Goričar, co-chair
  • Sara Redenšek Trampuž
  • Tanja Blagus
  • David Vogrinc

Endorsed and supported by

HORIZON-WIDERA-action: PharmGenHUB (GA No. 101059870)

H2020 MSC ITN-action: TranSYS (GA No. 860895)

H2020 research and innovation programme: ERA Chair CONI (GA No. 951851)

The course is endorsed by ERA Chair CONI, funded from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 951851. The website reflects only the Authors' view. The Research Executive Agency is not responsible for any use that may be made of the information this website contains.

2006 - Univerza v Ljubljani, Medicinska fakulteta, Institut za biokemijo.